These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12358998)

  • 1. Treatment of asthmatic patients with a cysteinyl leukotriene receptor-1 antagonist montelukast (Singulair), decreases the eosinophil survival-enhancing activity produced by peripheral blood mononuclear leukocytes in vitro.
    Becler K; Håkansson L; Rak S
    Allergy; 2002 Nov; 57(11):1021-8. PubMed ID: 12358998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells.
    Virchow JC; Faehndrich S; Nassenstein C; Bock S; Matthys H; Luttmann W
    Clin Exp Allergy; 2001 Jun; 31(6):836-44. PubMed ID: 11422147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.
    Rorke S; Jennison S; Jeffs JA; Sampson AP; Arshad H; Holgate ST
    Thorax; 2002 Apr; 57(4):323-7. PubMed ID: 11923550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of montelukast in the treatment of asthma and allergic rhinitis.
    Nayak A
    Expert Opin Pharmacother; 2004 Mar; 5(3):679-86. PubMed ID: 15013935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children.
    Gagro A; Aberle N; Rabatić S; Ajduk J; Jelacić J; Dekaris D
    Clin Exp Allergy; 2004 Jun; 34(6):939-44. PubMed ID: 15196283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ONO-1078 (pranlukast) on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthma.
    Tohda Y; Nakahara H; Kubo H; Haraguchi R; Fukuoka M; Nakajima S
    Clin Exp Allergy; 1999 Nov; 29(11):1532-6. PubMed ID: 10520082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast inhibition of resting and GM-CSF-stimulated eosinophil adhesion to VCAM-1 under flow conditions appears independent of cysLT(1)R antagonism.
    Robinson AJ; Kashanin D; O'Dowd F; Williams V; Walsh GM
    J Leukoc Biol; 2008 Jun; 83(6):1522-9. PubMed ID: 18332235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast inhibits interleukin-5 mRNA expression and cysteinyl leukotriene production in ragweed and mite-stimulated peripheral blood mononuclear cells from patients with asthma.
    Frieri M; Therattil J; Wang SF; Huang CY; Wang YC
    Allergy Asthma Proc; 2003; 24(5):359-66. PubMed ID: 14619337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma.
    Stelmach I; Jerzynska J; Kuna P
    J Allergy Clin Immunol; 2002 Feb; 109(2):257-63. PubMed ID: 11842294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial.
    Pizzichini E; Leff JA; Reiss TF; Hendeles L; Boulet LP; Wei LX; Efthimiadis AE; Zhang J; Hargreave FE
    Eur Respir J; 1999 Jul; 14(1):12-8. PubMed ID: 10489822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of montelukast on eosinophil apoptosis: induced sputum findings of patients with mild persistent asthma.
    Abadoglu O; Mungan D; Aksu O; Erekul S; Misirligil Z
    Allergol Immunopathol (Madr); 2005; 33(2):105-11. PubMed ID: 15808118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of treatment with montelukast on in vitro interleukin-10 production of mononuclear cells of children with asthma.
    Stelmach I; Majak P; Jerzynska J; Kuna P
    Clin Exp Allergy; 2005 Feb; 35(2):213-20. PubMed ID: 15725194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
    Reiss TF; Chervinsky P; Dockhorn RJ; Shingo S; Seidenberg B; Edwards TB
    Arch Intern Med; 1998 Jun; 158(11):1213-20. PubMed ID: 9625400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
    Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW
    Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma.
    Stelmach I; Jerzynska J; Kuna P
    Clin Exp Allergy; 2002 Feb; 32(2):264-9. PubMed ID: 11929492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group.
    Altman LC; Munk Z; Seltzer J; Noonan N; Shingo S; Zhang J; Reiss TF
    J Allergy Clin Immunol; 1998 Jul; 102(1):50-6. PubMed ID: 9679847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
    Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast.
    Minoguchi K; Kohno Y; Minoguchi H; Kihara N; Sano Y; Yasuhara H; Adachi M
    Chest; 2002 Mar; 121(3):732-8. PubMed ID: 11888953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.